Delivery Order SPE2DB20D1050-SPE2DB25FH91C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,736.37 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract, executed on June 18, 2025, with an ultimate completion date of June 20, 2025, utilizes firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count packaging) under a firm fixed-price contract valued at $7,215.32. The award, which must be completed by September 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH91CDelivery Order
The Defense Logistics Agency awarded a $6,163.17 delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Oxcarbazepine 300 milligrams per 5 milliliters suspension, with a completion date of September 16, 2025. The award was made on a firm fixed price basis with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee for this pharmaceutical supply delivery order. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. Oxcarbazepine is an anticonvulsant medication used in the treatment of seizure disorders and neuropathic pain conditions, and this order fulfills federal medical procurement needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor, regularly supplies generic and brand-name medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet government pharmaceutical procurement requirements through open competition and flexible contract vehicles designed to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/15/25 |